Skip to content
Research/Gene Therapy/AAV9-Follistatin

AAV9-Follistatin

AAV9-Follistatin is a gene therapy approach that uses an adeno-associated virus (AAV9) vector to deliver the follistatin gene. Follistatin is a protein that inhibits myostatin, a negative regulator of muscle growth, potentially enhancing muscle mass and strength. This therapy is significant for longevity and health optimization as it may help counteract age-related muscle loss and improve overall physical function.

Member access required

Clinical protocols and outcomes data are available to AXIFI Members and Providers.